Nexus Pharmaceuticals Launches Fluorescein 2 mL

Nexus Pharmaceuticals introduces a 2 mL vial of Fluorescein Injection, USP 25%, enhancing diagnostic options for eye care professionals and reinforcing its commitment to specialty injectable solutions.